The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Related News Articles

Headline
Senate and House lawmakers May 1 grilled UnitedHealth Group CEO Andrew Witty about the continued fallout from the Feb. 22 cyberattack on Change Healthcare —…
Headline
“If you are asking yourself how a cyberattack on a single company could cause such massive damage, you are asking the right question,” an AHA advertorial in…
Headline
The AHA April 29 provided the Senate Committee on Finance and House Energy and Commerce Subcommittee on Oversight and Investigations an update regarding…
Headline
The Department of Health and Human Services’ Office for Civil Rights April 19 launched a webpage answering HIPAA-related FAQs about the Change Healthcare…
Headline
U.S. and European agencies April 18 recommended organizations implement certain best practices to protect against the latest versions of Akira ransomware,…
Headline
In a statement submitted to the House Energy and Commerce Health Subcommittee for a hearing April 17 on President Biden’s fiscal year 2025 Health and Human…